| Futibatinib |
Tablet |
II (Paddle) |
50 |
50 mM phosphate dihydrogen phosphate buffer, pH 6.8 with 0.5% Tween 80 |
900 |
5, 10, 15, 30, 45, 60 and 75 |
2023/11/30 |
| Gabapentin |
Tablet |
I (Basket) |
100 |
Modified simulated gastric fluid (SGF) |
900 |
1, 2, 4, 6, 8, 10, 12, 14 and 16 hours |
2023/11/30 |
| Gabapentin |
Capsule |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Gabapentin |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Gabapentin Enacarbil |
Tablet (Extended Release) |
II (Paddle) |
50 |
10 mM Phosphate buffer at pH 7.4 with 1.0 % SLS |
500 (for 300 mg); 900 (for 600 mg) |
0.5, 1, 2, 4, 6, 8, 12 and 24 hours |
2013/01/31 |
| Galantamine HBr |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Galantamine HBr |
Capsule (Extended Release) |
II (Paddle) |
50 |
50 mM potassium dihydrogen phosphate buffer pH 6.5 |
900 |
1, 4, 10 and 12 hours |
2006/01/20 |
| Ganaxolone |
Suspension |
II (Paddle) |
25 |
2.8% SDS |
900 |
2.5, 5, 7.5, 10, 15, 20 and 30 |
2023/11/30 |
| Ganciclovir |
Capsule |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Gefitinib |
Tablet |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Gemfibrozil |
Tablet |
|
|
Refer to USP |
|
|
2007/07/25 |
| Gemifloxacin Mesylate |
Tablet |
II (Paddle) |
50 |
0.01 N HCl |
900 |
10, 20, 30 and 45 |
2007/01/03 |
| Gepirone Hydrochloride |
Tablet, Extended Release |
II (Paddle) |
50 |
0.01 N HCl |
900 |
1, 2, 4, 8, 10, 12, 14, 16, 18 and 20 hours |
2025/06/23 |
| Gepotidacin Mesylate |
Tablet |
II (Paddle) |
75 |
0.1 N HCl |
500 |
5, 10, 15, 20, 25, 30 and 45 |
2026/01/28 |
| Gilteritinib Fumarate |
Tablet |
II (Paddle) |
50 |
0.1 N HCl |
900 |
10, 15, 20, 30 and 45 |
2020/08/27 |
| Givinostat Hydrochloride |
Suspension |
II (Paddle) |
30 |
Phosphate Buffer, pH 4.5 |
500 |
5, 10, 15, 20, 30, 45 and 60 |
2026/01/28 |
| Glimepiride |
Tablet |
II (Paddle) |
75 |
Phosphate Buffer, pH 7.8 |
900 |
5, 10, 15 and 30 |
2004/07/23 |
| Glimepiride/Pioglitazone HCl |
Tablet |
II (Paddle) |
75 |
For Pioglitazone: pH 2.0, HCl Buffer. For Glimepiride: pH 6.8, Sodium Phosphate Buffer with 0.2% sodium dodecyl sulfate |
900 |
For Pioglitazone: 10, 15, 20, 30 and 45; For Glimepiride: 10, 15, 20 and 30 |
2009/04/02 |
| Glimepiride/Rosiglitazone Maleate |
Tablet |
II (Paddle) |
75 |
0.01 M HCl with 0.5% Sodium Dodecyl Sulfate |
900 |
5, 10, 15, 30, 45 and 60 |
2007/01/03 |
| Glipizide |
Tablet (Extended Release) |
II (Paddle) |
50 |
Simulated Intestinal Fluid without pancreatin, pH 7.5 |
900 |
1, 2, 4, 8, 16 hours and until at least 80% dissolved |
2008/04/10 |
请输入需要查询的英文药品通用名称，至少3个字符.